Study of Avutometinib (VS-6766) +Defactinib With Gemcitabine and Nab-paclitaxel in Patients With Pancreatic Cancer

Clinical trial NCT05669482 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT05669482
Sponsor: Verastem, Inc.
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

KRAS Activating Mutation Metastatic Cancer Pancreas Cancer Neoplasms Pancreatic Malignant Neoplasm of Pancreas

Start date: 2023-03-22
Primary completion: 2026-08-31
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.